Live Breaking News & Updates on மீசா பயோடெக் இன்க்|Page 2

Stay updated with breaking news from மீசா பயோடெக் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Thermo Fisher Scientific Reports First Quarter 2021 Results


Thermo Fisher Scientific Reports First Quarter 2021 Results
News provided by
Share this article
Share this article
WALTHAM, Mass., April 29, 2021 /PRNewswire/  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 3, 2021.
First Quarter 2021 Highlights
First quarter GAAP diluted earnings per share (EPS) increased 198% to $5.88.
First quarter adjusted EPS increased 145% to $7.21.
Continued significant role in enabling the COVID-19 response, helping to scale vaccine production and supporting testing globally, and accelerated growth in the base business.
Strong start to the year in terms of product launches including two Thermo Scientific Orbitrap Exploris Gas Chromatography-Mass Spectrometers, which bring high-resolution analysis to a range of applications, including toxicology and metabolomics, the Thermo Scientific Spectra Ultra electron micro ....

United States , Marcn Casper , Rafael Tejada , Life Sciences Solutions , Unity Lab Services , Services Segment , Ppd Inc , Thermo Fisher , Life Sciences Solutions Segment , Mesa Biotech Inc , Exchange Rate Effect On Cash , Thermo Fisher Scientific Inc , Fisher Scientific , Our Mission , Laboratory Products , Thermo Fisher Scientific , Thermo Scientific Spectra Ultra , Kingfisher Apex Purification System , Thermo Scientific Aerosolsense Sampler , North America , Mesa Biotech , Sciences Solutions Segment , Instruments Segment , Diagnostics Segment , Thermo Scientific , Applied Biosystems ,

RSV Diagnostics Market Size Estimated to Reach $1.3 Billion by 2026


RSV Diagnostics Market Segment Analysis – By Geography
The RSV Diagnostics Market based on Geography can be further segmented into North America (U.S., Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand and Rest of Asia-Pacific), South America(Brazil, Argentina and others), and RoW (Middle East and Africa). North America held the largest share in 2020 with 37.2% of overall market. The growth in this segment is owing to the factors such as increasing number of strategic partnerships among the pharmaceutical companies and in vitro diagnostic manufacturing companies, rising incidences of RSV infections and an increasing infant population. The growing innovations in new technologies such as filament-based antibody detection assays, thin layer-based amperometric enzyme immunoassay (EIA), and multiplex virus testing in the region is propelling the growth of the market. Asia ....

United States , United Kingdom , Andhra Pradesh , New Zealand , South Korea , Venkat Reddy , Our Custom Research Services , Company Name , Mesa Biotech Inc , Quidel Corporation , Bio Rad Laboratories Inc , Thermofisher Scientifc Inc , Thermo Fisher Scientific Inc , Abbott Laboratories , Hoffmann La Roche , Growing Adoption , Molecular Diagnostic Devices , Syncytial Virus , Diagnostics Market , Market Segment Analysis , Molecular Diagnostics , Direct Fluorescent Antibody , Rapid Antigen Detection Tests , Diagnostic Imaging , Flow Cytometry , Chromatographic Immunoassay ,